Simplifying the Approach to Primary Aldosteronism

Course overview

Primary aldosteronism (PA), once considered a rare secondary cause of resistant hypertension and hypokalemia, is now recognized as a highly prevalent and frequently underdiagnosed syndrome affecting patients across the full spectrum of blood pressure, most without hypokalemia. Despite the availability of effective targeted therapies, screening rates remain low, and most at-risk individuals are never tested. Barriers include limited awareness and perceived complexity of the diagnostic process. Recent consensus guidelines from the American Heart Association/American College of Cardiology and the Endocrine Society seek to simplify screening and improve case detection.